Microvascular Decompression for a Patient with a Glossopharyngeal Neuralgia: A Technical Note

The glossopharyngeal neuralgia (GPN) constitutes approximately 0.2-1.3% of all facial pain syndromes. The GPN is a syndrome of neuropathic pain characterized by paroxysmal pain episodes localized in the posterior tongue, tonsil, throat, or external ear canal. The first-line treatment is pharmacologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordónez-Rubiano, Edgar Gerardo, García-Chingaté, Cristian C, Rodríguez-Vargas, Saney, Cifuentes-Lobelo, Hernando A, Perilla-Cepeda, Tito A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Neurosurgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606712/
https://www.ncbi.nlm.nih.gov/pubmed/28948114
http://dx.doi.org/10.7759/cureus.1494
Descripción
Sumario:The glossopharyngeal neuralgia (GPN) constitutes approximately 0.2-1.3% of all facial pain syndromes. The GPN is a syndrome of neuropathic pain characterized by paroxysmal pain episodes localized in the posterior tongue, tonsil, throat, or external ear canal. The first-line treatment is pharmacological. Patients who are refractory to medical therapy can be treated surgically with microvascular decompression (MVD) or sectioning the IX nerve and the upper rootlets of the X nerve. We aim to describe the technical nuances of MVD of the IX cranial nerve with a targeted inferior mini-craniotomy in a patient with a neurovascular compression.

Ejemplares similares